Skip to main content
VulnerabilityPublished Updated

CVE-2026-18193: IBM · Improper Privilege Management

Affects IBMSource CVE Database V5

0

Not known to be exploited · CVSS 8.9 High.

Data as of 26 Oct 2026, 17:16 UTC

CVSS 3.1 base score
8.9High
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.4% chance of exploitation in 30 days – higher than 39% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:H/I:H/A:L

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 13 Aug 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

Affected software

ProductAffectedFixed in
IBMAffected
  • 7.3 – 7.6
4 affected builds
Fixed in–

CPE configurations (8)

  • cpe:2.3:a:ibm:i:7.6:*:*:*:*:*:*:*
  • cpe:2.3:a:ibm:i:7.6.0:*:*:*:*:*:*:*
  • cpe:2.3:a:ibm:i:7.5:*:*:*:*:*:*:*
  • cpe:2.3:a:ibm:i:7.5.0:*:*:*:*:*:*:*
  • cpe:2.3:a:ibm:i:7.4:*:*:*:*:*:*:*
  • cpe:2.3:a:ibm:i:7.4.0:*:*:*:*:*:*:*

AI-suggested

Until a patch is available, consider restricting network access to affected systems and applying any recommended temporary mitigations from IBM if released.

Description

CVE-2026-18193 is a high severity vulnerability in IBM i versions 7.3, 7.4, 7.5, and 7.6 that allows a remote attacker to bypass security restrictions due to improper validation of user-controlled addresses. This improper privilege management flaw can lead to a complete compromise of confidentiality and integrity, with limited impact on availability.

References

Community reviews

Loading reviews…